SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kosan BioSciences -- KOSN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tom pope11/23/2004 8:20:58 AM
   of 933
 
07:37 ET Kosan Biosciences NSCLC Phase II Trial Discontinued (KOSN) 6.55: The KOS-862 trial in non-small cell lung cancer was terminated as the trial did not meet the primary objective of tumor response in the first step of the two-stage Simon trial design. The breast cancer trial initiated in February 2004 continues to enroll patients and is expected to generate sufficient data for an interim analysis in the first half of 2005; the prostate trial is expected to commence at multiple sites this calendar quarter.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News